SANTA MONICA, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Kite Pharma, Inc. (NASDAQ: KITE) (“Kite”) and Cell Design Labs, Inc. today announced a research collaboration and license agreement to develop ...
Kite Pharma and Cell Design Labs said today they will partner to develop next-generation, precision-controlled chimeric antigen receptor (CAR) T-cell immunotherapy candidates using Cell Design Labs’ ...
While kites have become more commercial and visually spectacular elsewhere, we continue to focus on creativity," he said. This year, only artists who design and build their own kites were invited to ...
Aecon and Skyport are launching a contest to design Bermudian kites, with the winning designs set to “be incorporated into actual kites that will be suspended from the ceilings in the new terminal.” ...
A kite designing contest has been launched to decorate the new terminal of LF Wade International Airport. The contest, held by Aecon Group Inc and Bermuda Skyport Corporation Ltd, called for community ...
Gilead Sciences and its Kite cell therapy subsidiary have agreed to acquire Cell Design Labs for up to approximately $567 million, in a deal designed to grow the buyers’ footprint in chimeric antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results